Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001193125-26-251817

Chief Medical Officer sold 3,786 shares at $55.62 ($210,577)

  • Chief Medical Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Patel Naimish Chief Medical Officer 2026-05-28 Option exercise +10,000 23,143 D: show line 1 in the form
Patel Naimish Chief Medical Officer 2026-05-29 Sale −3,786 $55.62 $210,577 19,357 D: show line 2 in the form
Open-market sales · 3,786 sh · avg $55.62 · $210,577

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Patel Naimish Chief Medical Officer 2026-05-28 Option exercise · Restricted Stock Units −10,000 20,000 D: show line 3 in the form
Loading xslF345X06/ownership.xml…